WO2019035227A1 - Gel-type cosmetic composition - Google Patents

Gel-type cosmetic composition Download PDF

Info

Publication number
WO2019035227A1
WO2019035227A1 PCT/JP2018/006791 JP2018006791W WO2019035227A1 WO 2019035227 A1 WO2019035227 A1 WO 2019035227A1 JP 2018006791 W JP2018006791 W JP 2018006791W WO 2019035227 A1 WO2019035227 A1 WO 2019035227A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic composition
guanylate
composition
acid
weight
Prior art date
Application number
PCT/JP2018/006791
Other languages
French (fr)
Japanese (ja)
Inventor
瞬 小林
貴大 鈴木
雅哉 金子
Original Assignee
味の素株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 味の素株式会社 filed Critical 味の素株式会社
Publication of WO2019035227A1 publication Critical patent/WO2019035227A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a gel cosmetic composition.
  • Thickeners are used in a wide variety of products, such as various industrial products and food products.
  • thickeners are used to enhance usability and stability and to prevent dripping.
  • an anionic water-soluble polymer such as carboxyvinyl polymer is very inexpensive, highly thick, has a small amount of gelation in addition to gelation in a small amount, is excellent in transparency, has a good feeling of use with little stickiness Since it exists, it is widely used for base thickening of a wide range of compositions such as skin care and hair care.
  • Non-Patent Document 1 Patent Document 1
  • an anionic water-soluble polymer is blended in a large amount to compensate for such a decrease in viscosity, stickiness, nulliness and stickiness occur during coating, resulting in an essential drawback that the feeling in use is impaired (Patent Document 1) 2).
  • water-soluble active ingredients have been proposed for skin care and hair care cosmetics, and many of them are composed of electrolytes.
  • water-soluble active ingredients such as an amino acid which is a component of a natural moisturizing factor, sodium pyrrolidone carboxylate which is an amino acid derivative, lactic acid, a polyamino acid and the like have excellent water retention function and can moisturize the skin.
  • ascorbic acid and its derivatives, and water-soluble active ingredients such as tranexamic acid are blended in many cosmetics as a skin-whitening ingredient.
  • Non-patent Document 2 adenosine 5'-phosphate, which is a kind of nucleotide, can be used as an active ingredient (for example, a blood circulation promoting agent, a hair restorer) in cosmetics.
  • a whitening agent containing guanine has been reported (Patent Document 5).
  • nucleotides can be used as thickeners (Non-patent Document 2).
  • An object of the present invention is to develop a product using a thickener which can be used instead of an anionic polymer and which is excellent in the feeling in use.
  • a predetermined composition containing a high concentration of guanylate has desired viscosity characteristics, and moreover, when applied to a body surface such as skin, the feeling of use is excellent. Therefore, the composition is a favorite which is frequently used on a daily basis among various applications in a wide range of fields such as various industrial products and foods, and a cosmetic which has a high need for feeling in use Are considered particularly suitable for use as
  • Guanylate is considered to be a highly safe component for subjects such as humans, because it is a umami component that is consumed on a daily basis. Therefore, also from the viewpoint of safety, guanylate is suitable for use as a cosmetic.
  • guanilic acid for adjusting physical properties of cosmetics or improving the feeling of use, in particular, as a thickener capable of improving the feeling of using cosmetics regardless of the presence of an electrolyte It is not known to use guanylate.
  • the present invention is as follows. [1] containing 2.0% by weight or more of guanylate in a water-soluble medium, Gel cosmetic composition having a pH of 4.0 to 7.0. [2] The gel cosmetic composition of the above-mentioned [1], which further comprises a cationic substance. [3] The gel cosmetic composition according to the above [1] or [2], wherein the cationic substance is a metal ion. [4] The gel cosmetic composition according to any one of the above [1] to [3], wherein the concentration of guanylate is 2.0 to 4.0% by weight. [5] The gel cosmetic composition according to any one of the above [1] to [4], which has a pH of 4.5 to 6.5.
  • the gel-like cosmetic composition is (i) completely free of RNA macromolecules and / or RNA constituents other than guanylate, or (ii) RNA constituents other than guanylate
  • the gel cosmetic composition according to any one of the above [1] to [9] which is not contained in the same amount as guanyl acid.
  • the gel cosmetic composition is a moisturizing agent.
  • the cosmetic composition of the present invention containing guanyl acid at a high concentration can exhibit the effects of having desired viscosity characteristics and being excellent in feeling in use. Since guanylate is considered to be a highly safe component to subjects such as humans, it can be said that the cosmetic composition of the present invention is also excellent in terms of safety.
  • the present invention comprises greater than 2.0% by weight of guanylate in an aqueous medium.
  • a gel cosmetic composition (hereinafter simply referred to as “composition”) having a pH of 4.0 to 7.0 is provided.
  • the composition of the present invention depends on various conditions such as the type and concentration of other components (eg, physiologically acceptable salt, water-soluble medium, water-soluble active ingredient, polyol) contained in the composition of the present invention. It also varies, but contains more than 2.0% by weight of guanylate in a water-soluble medium. By having a pH of 4.0 to 7.0, sufficient gelling of the aqueous medium can be achieved. 8.
  • the composition of the present invention has a higher concentration (e.g., 4.0% by weight or more, 5.0% by weight or more, and 8.) from the viewpoint of achieving higher viscosity gelation and / or improving the feeling in use, etc. Guanylic acid can be included at 0 wt% or more, 10 wt% or more).
  • composition of the present invention is also, for example, 50% by weight or less, preferably 30% by weight or less, more preferably 25% by weight or less, still more preferably 20% by weight or less, from the viewpoint of cost reduction due to reduction of use amount. It may contain guanylate, particularly preferably at a concentration of up to 15% by weight.
  • the concentration of guanylate may be determined focusing on a specific feeling of use. For example, when focusing on the thickness at the time of application and / or the non-stickiness after application, the concentration of guanylate may be preferably 2.0 to 4.0% by weight.
  • RNA macromolecules in particular, RNA macromolecules from which a conventional composition (eg, buffer solution) is extracted, in particular, In the case where the conventional composition contains guanylate, it is assumed that the conventional composition contains guanylate as a result of the formation of guanylate by the degradation of the RNA polymer.
  • the composition of the present invention is an RNA polymer and an RNA component other than guanylate [eg, guanosine 5'-phosphate other than guanylate (guanosine 5'-diphosphate and guanosine It differs from conventional compositions containing RNA macromolecules because it does not need to contain substantially 5'-triphosphate), adenosine 5'-phosphate, cytidine 5'-phosphate, uridine 5'-phosphate). .
  • the composition of the present invention may be completely free of (i) RNA macromolecules and / or RNA components other than guanylate.
  • composition of the present invention may also contain (ii) no RNA component other than guanylate in an equivalent amount to guanylate.
  • RNA component other than guanylate in an equivalent amount to guanylate.
  • each of the RNA components other than guanylate similarly produced by degradation of RNA macromolecule eg, other than guanylate It is assumed that guanosine 5'-phosphate, adenosine 5'-phosphate, cytidine 5'-phosphate, uridine 5'-phosphate) is also included in the same amount as guanylate.
  • composition of the present invention does not need to substantially contain RNA macromolecules, it can be avoided to contain any RNA component other than guanylate in an amount equivalent to guanylate.
  • any RNA component other than guanylate eg, guanosine 5'-phosphate, adenosine 5'-phosphate
  • Cytidine 5'-phosphate, uridine 5'-phosphate, preferably all of them is, for example, 1/2 wt.% Or less, preferably 1/5 wt.
  • composition of the present invention may also contain adenines (e.g., adenine, adenosine, adenosine 5'-monophosphate, adenosine 5'-diphosphate, adenosine 5'-triphosphate, glucosyl adenosine) as RNA components other than guanylate. May not be included.
  • adenines e.g., adenine, adenosine, adenosine 5'-monophosphate, adenosine 5'-diphosphate, adenosine 5'-triphosphate, glucosyl adenosine
  • the water-soluble medium includes, for example, an aqueous solution, and a mixed solvent of an aqueous solution and an organic solvent.
  • the aqueous solution may or may not have a buffering capacity.
  • water eg, distilled water, sterile distilled water, purified water, physiological saline
  • phosphate buffer Tris-hydrochloric acid buffer
  • TE Tris-EDTA
  • carbonate buffer borax Acid buffer
  • tartaric acid buffer glycine buffer
  • citrate buffer acetate buffer
  • a hydrophilic organic solvent eg, alcohol, acetone
  • the volume of the aqueous solution is not particularly limited, but is preferably larger than the volume of the organic solvent.
  • the volume of the aqueous solution in the mixed solvent is more preferably 1.5 times or more, still more preferably 2 times or more, particularly preferably 3 times or more, 4 times or more or 5 times the volume of the organic solvent It may be more than.
  • the aqueous medium may preferably be an aqueous solution, more preferably water.
  • compositions of the invention can also be defined in terms of water content.
  • the water content in the composition of the present invention is not particularly limited as it varies depending on the types and concentrations of other components contained in the composition of the present invention and various conditions such as pH, etc. From the viewpoint of achieving higher viscosity gelation with an acid and / or improving the feeling in use, it may be, for example, 50% by weight or more, preferably 60% by weight or more, and more preferably 70% by weight or more.
  • the water content may also be, for example, 99.5 wt% or less, preferably 99 wt% or less, more preferably 98 wt% or less. More specifically, the water content may be, for example, 50 to 99.5% by weight, preferably 60 to 99% by weight, more preferably 70 to 98% by weight.
  • the pH of the composition of the present invention is 4.0 to 7.0.
  • the composition of the present invention can sufficiently support the achievement of gelation by guanylate when the pH is in the range of 4.0 to 7.0.
  • the pH is preferably in the range of 4.5 to 6.5 from the viewpoint of achieving higher viscosity gelation and / or improving the feeling in use.
  • the composition of the present invention may further contain a cationic substance.
  • cationic substances include metal ions, arginine, lysine, histidine, ammonium ions, and quaternary amines (eg, tetraalkylamines).
  • Cationic substances can support the formation of gels by guanylate.
  • the composition of the present invention can contain one or more (e.g., two or three) cationic substances. As the cationic substance, metal ions are preferred.
  • monovalent metal ions eg, sodium ion, potassium ion
  • divalent metal ions eg, calcium ion, magnesium ion, zinc ion
  • trivalent metal ions eg, aluminum ion
  • concentration of the cationic substance may be, for example, 0.01 to 5.0, preferably 0.1 to 3.0, and more preferably 0.2 to 1.5.
  • compositions of the invention may also further comprise inosinic acid.
  • Inosinic acid can enhance the action of guanylate in combination with guanylate.
  • inosinic acid can enhance refreshing feeling. Since inosinic acid is an umami component that is consumed on a daily basis, it is considered to be a component that is highly safe for subjects such as humans. Therefore, from the viewpoint of safety as well, inosinic acid is considered to be suitable for use as a cosmetic.
  • the concentration of inosinic acid contained in the composition of the present invention is not particularly limited because it also varies depending on the types and concentrations of other components contained in the composition of the present invention and various conditions such as pH. From the viewpoint of exerting the desired action, it may be, for example, 0.05% by weight or more, preferably 0.1% by weight or more, and more preferably 0.2% by weight or more.
  • the concentration of inosinic acid is also, for example, 10% by weight or less, preferably 5% by weight or less, more preferably 2% by weight or less, and still more preferably 1% by weight or less, from the viewpoint of cost reduction due to reduction of use amount. Particularly preferably, the concentration may be 0.5% by weight or less.
  • composition of the present invention can also be specified by the relative amount of inosinic acid to guanylate in terms of exerting the desired action.
  • the weight ratio of inosine to guanylate may be, for example, in the range of 1/100 to 1/1.
  • the weight ratio may preferably be in the range of 1/50 to 1/2, more preferably 1/20 to 1/5.
  • composition of the present invention may also further comprise a polyol.
  • a polyol for example, a dihydric alcohol (eg, ethylene glycol, propylene glycol, 1,3-propanediol, 1,2-butylene glycol, 1,3-butylene glycol, 2,3-butylene glycol, 1,4-dioxane) Butanediol, 2-butene-1,4-diol, 1,5-pentanediol, 1,2-pentanediol, isoprene glycol, hexylene glycol, diethylene glycol, dipropylene glycol), trihydric alcohol (eg, glycerin, tri) Examples include methylolpropane), tetrahydric alcohols (eg, diglycerin, pentaerythritol, 1,2,6-hexanetriol), and higher value alcohols.
  • a dihydric alcohol eg, ethylene glycol, propylene glyco
  • higher valence alcohols include sugar alcohols (eg, monosaccharide alcohols such as sorbitol and mannitol, disaccharide alcohols such as trehalose, and polysaccharide alcohols such as hyaluronic acid), and di- to tetra-valent as described above.
  • sugar alcohols eg, monosaccharide alcohols such as sorbitol and mannitol, disaccharide alcohols such as trehalose, and polysaccharide alcohols such as hyaluronic acid
  • di- to tetra-valent as described above.
  • Polymers of alcohol eg, polyglycol, polyglycerin
  • the polyhydric alcohol is preferably a di- to tetra-hydric alcohol, more preferably a di- or tri-hydric alcohol.
  • One or more types of polyhydric alcohols can be used in combination.
  • the concentration of the polyol contained in the composition of the present invention is not particularly limited as it varies depending on various conditions such as the type and concentration of the other components contained in the composition of the present invention. It may be 2% by weight or more, preferably 0.5% by weight or more, more preferably 1.0% by weight or more, still more preferably 2.0% by weight or more, and particularly preferably 5.0% by weight or more .
  • the concentration of the polyol is also, for example, 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, still more preferably 15% by weight or less, particularly from the viewpoint of cost reduction due to reduction of use amount.
  • the concentration may be 10% by weight or less.
  • composition of the present invention may further contain one or more (for example, two, three or four) water-soluble active ingredients.
  • the water-soluble active ingredient used in the present invention is an active ingredient other than the above-mentioned ingredients and has any action (eg, biological action or chemical action) useful as a cosmetic.
  • the water-soluble active ingredient used in the present invention may be an electrolyte.
  • the water soluble active ingredient may be present as an ionic substance.
  • the ionic substance includes, for example, an anionic substance having an anionic moiety, a cationic substance having a cationic moiety, and a zwitterionic substance having both an anionic moiety and a cationic moiety.
  • the anionic moiety includes, for example, a carboxylate group, a phosphate group, a sulfonate group, a sulfate group and a ditorate group.
  • the cationic moiety includes an ammonium group, a phosphonium group, a guanidino group and an imidazoyl group.
  • the hydrogen atom in the ammonium group and the phosphonium group may be substituted (eg, mono-substituted, di-substituted, tri-substituted) with a group such as a hydrocarbon group (eg, alkyl).
  • the water-soluble active ingredient used in the present invention may also be a low molecular weight compound.
  • low molecular weight compound refers to a compound having a molecular weight of 1,500 or less.
  • Low molecular weight compounds are natural compounds or synthetic compounds.
  • the molecular weight of the low molecular weight compound may be 1200 or less, 1000 or less, 900 or less, 800 or less, 700 or less, 600 or less, 500 or less, 400 or less, or 300 or less.
  • the molecular weight of the low molecular weight compound may also be 30 or more, 40 or more, or 50 or more.
  • the low molecular weight compounds include, for example, amino acids, oligopeptides, vitamins, nucleosides, nucleotides, oligonucleotides, monosaccharides, oligosaccharides, lipids, fatty acids, and metabolites thereof.
  • the water soluble active ingredient used in the present invention may also be a moisturizer, a skin lightening agent, a hair restorer, or an anti-wrinkle agent.
  • the water soluble active ingredient may also be a moisturizer, a hair restorer, or an anti-wrinkle agent.
  • a combination of two or more (for example, two or three) selected from the group consisting of a moisturizer, a whitening agent, a hair restorer, and an anti-wrinkle agent (preferably, a moisturizer, a hair restorer, and an anti-wrinkle agent) Can also be used.
  • Humectants include pyrrolidone carboxylic acid, ascorbic acid 2-glucoside, polyaspartic acid, 3-acetyl-2-ethoxycarbonyl-2-methyl-1,3-thiazolidine-4-carboxylic acid, amino acids (eg, glutamic acid, asparagine) Acid, arginine, lysine, histidine, ornithine, glycine, alanine, valine, leucine, isoleucine, serine, threonine, asparagine, glutamine, cysteine, cystine, methionine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline) and mixtures thereof Glycylglycine, alanyl glutamine, dipeptide-2 (valyl tryptophan), dipeptide-4 (cysteinylglycine), dipeptide-8 (alanyl hydroxyproline), dipepti -9 (Guru Tamil lysine
  • the salts include, for example, inorganic salts and organic salts.
  • inorganic salt for example, salts of metals (eg, monovalent metals such as sodium and potassium and divalent metals such as calcium, magnesium and zinc), inorganic acids (eg, hydrogen chloride, hydrogen bromide) And salts of sulfuric acid and phosphoric acid, and salts of inorganic bases (eg, ammonia).
  • metals eg, monovalent metals such as sodium and potassium and divalent metals such as calcium, magnesium and zinc
  • inorganic acids eg, hydrogen chloride, hydrogen bromide
  • salts of sulfuric acid and phosphoric acid eg, ammonia
  • organic salt examples include salts of organic acids (eg, acetic acid, lactic acid, citric acid, tartaric acid, maleic acid, fumaric acid, monomethyl sulfuric acid, aspartic acid, and glutamic acid), and organic bases (eg, ethylene diamine, propylene diamine, Salts of ethanolamine, monoalkylethanolamine, dialkylethanolamine, diethanolamine, triethanolamine, lysine, arginine, histidine, ornithine) can be mentioned.
  • organic acids eg, acetic acid, lactic acid, citric acid, tartaric acid, maleic acid, fumaric acid, monomethyl sulfuric acid, aspartic acid, and glutamic acid
  • organic bases eg, ethylene diamine, propylene diamine, Salts of ethanolamine, monoalkylethanolamine, dialkylethanolamine, diethanolamine, triethanolamine, lysine, arginine, histidine, ornithine
  • skin lightening agents examples include vitamin C, vitamin C derivatives (eg, vitamin C glycosides such as L-ascorbic acid 2-glycoside), cysteine, tranexamic acid, hydroquinone, arbutin, ceramide, kojic acid, ellagic acid, plants Extracts as well as their salts are included.
  • vitamin C vitamin C derivatives (eg, vitamin C glycosides such as L-ascorbic acid 2-glycoside), cysteine, tranexamic acid, hydroquinone, arbutin, ceramide, kojic acid, ellagic acid, plants Extracts as well as their salts are included.
  • vitamin C vitamin C derivatives
  • cysteine eg., cysteine, tranexamic acid, hydroquinone, arbutin, ceramide, kojic acid, ellagic acid, plants Extracts as well as their salts are included.
  • One or more kinds of skin lightening agents can be used in combination.
  • a hair growth agent for example, pantothenic acid and derivatives thereof, allantoin, biotin, mononitroguaiacol, adenosine, pentadecanoic acid glyceride, dialkyl monoamine derivative, choleus extract, chlorophyll, photosensitizer, estradiol, ethynyl estradiol, pyridoxine hydrochloride, thioxolone hydrochloride, minoxidil And sulfur, organic sulfur substances, dipeptide-9 (glutamyl lysine), and salts thereof.
  • One or two or more hair growth agents can be used in combination.
  • Anti-wrinkle agents include, for example, alpha hydroxy acids, ascorbyl palmitate, ascorbyl tetrahexyl decanoate, acetyl hexapeptide-8, and salts thereof.
  • One or more anti-wrinkle agents can be used in combination.
  • the composition of the present invention may be a defined composition.
  • the term "defined” for the composition of the invention means that the ingredients and amounts contained in the composition of the invention are specified. The preparation of such defined compositions can be carried out by using known ingredients in specific amounts. Therefore, the composition of the present invention may be a material whose component or amount thereof is unknown, or a material whose component or amount may vary [eg, natural products (eg, animals such as animals, plants, fish, microorganisms, etc., Or non-living materials such as minerals) (eg, extracts, processed products) may not be included.
  • the composition of the present invention can also be defined in terms of thickness (coating feeling) at the time of coating.
  • the composition of the present invention can have the characteristic that the vibration stress at the intersection of the storage elastic modulus G 'and the loss elastic modulus G' 'is 10 Pa or more. If the vibration stress at the intersection of the storage elastic modulus G ′ and the loss elastic modulus G ′ ′ is 10 Pa or more, a sufficient thickness (application feeling) at the time of application can be expected.
  • the vibration stress at such an intersection is preferably 15 Pa or more, more preferably 20 Pa or more, and still more preferably 25 Pa or more.
  • Such determination of the vibrational stress at the point of intersection can be performed as follows.
  • strain dependence measurement of dynamic viscoelasticity may be performed using a rheometer (AR-G2, TA Instruments) for a test sample (measuring jig: aluminum cone plate diameter 40 mm, cone Angle 2 °, measurement temperature: 35 ° C.).
  • composition of the present invention also contains other components such as thickeners, stabilizers, pH adjusters, preservatives, UV inhibitors, perfumes, dyes, etc. other than the above-mentioned thickening components (eg, guanylate). It may be.
  • thickeners stabilizers, pH adjusters, preservatives, UV inhibitors, perfumes, dyes, etc.
  • preservatives e.g. UV inhibitors, perfumes, dyes, etc.
  • UV inhibitors eg, guanylate
  • perfumes e.g, guanylate
  • thickeners other than the above-mentioned thickening component, for example, carrageenan, dextrin, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyacrylic acid, polymethacrylic acid, carboxyvinyl polymer (carbomer), ( And acrylic acid / alkyl acrylate (C10-30) copolymers, xanthan gum.
  • carrageenan dextrin
  • methylcellulose ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose
  • polyacrylic acid polymethacrylic acid
  • carboxyvinyl polymer carboxyvinyl polymer (carbomer)
  • acrylic acid / alkyl acrylate (C10-30) copolymers xanthan gum.
  • the weight ratio of the thickening agent to the above-mentioned thickening component may for example be less than 1.0, preferably less than 0.8, more preferably less than 0.4, even more preferably less than 0.2, particularly preferably less than 0.1.
  • the stabilizer examples include ascorbic acid, sodium metabisulfite and EDTA.
  • pH adjusting agents examples include aqueous solutions (buffer solutions) as described above, acidic substances such as hydrochloric acid, and basic substances such as sodium hydroxide.
  • preservatives examples include ethyl parahydroxybenzoate, sodium benzoate, salicylic acid, sorbic acid, parabens (such as methyl paraben and propyl paraben), and sodium bisulfite.
  • UV inhibitors examples include UV absorbers (eg, t-butyl methoxydibenzoylmethane, ethylhexyl methoxycinnamate, oxybenzone-3), and UV scattering agents (eg, titanium oxide, zinc oxide).
  • UV absorbers eg, t-butyl methoxydibenzoylmethane, ethylhexyl methoxycinnamate, oxybenzone-3
  • UV scattering agents eg, titanium oxide, zinc oxide
  • the pigment examples include organic pigments (eg, red pigment such as red No. 201, blue pigment such as blue No. 404, orange pigment such as orange No. 203, yellow pigment such as yellow No. 205, green pigment such as green No. 3) Organic lake pigments such as zirconium lake, natural pigments such as chlorophyll, and inorganic pigments (eg, white pigments such as titanium oxide, colored pigments such as iron oxide, extender pigments such as talc, pearl pigments such as mica) Be
  • organic pigments eg, red pigment such as red No. 201, blue pigment such as blue No. 404, orange pigment such as orange No. 203, yellow pigment such as yellow No. 205, green pigment such as green No.
  • Organic lake pigments such as zirconium lake
  • natural pigments such as chlorophyll
  • inorganic pigments eg, white pigments such as titanium oxide, colored pigments such as iron oxide, extender pigments such as talc, pearl pigments such as mica
  • the composition of the present invention is effective (e.g., 0.01 mg or more) at a desired site (e.g., skin, hair, body hair, scalp) of a subject (e.g., a mammal such as a human, animals such as birds, reptiles) It can be used by applying 100 g).
  • a desired site e.g., skin, hair, body hair, scalp
  • a subject e.g., a mammal such as a human, animals such as birds, reptiles
  • a desired site e.g., skin, hair, body hair, scalp
  • a subject e.g., a mammal such as a human, animals such as birds, reptiles
  • the subject is a human
  • a human who can be a user or an applicator of the composition of the present invention can enjoy the effect of feeling of use.
  • the subject is a human.
  • the condition of the subject to which the composition of the present invention is applied may be that the above site has a healthy condition, or the above site may have an abnormal condition (eg, a disease) .
  • abnormal conditions include, for example, rough skin, dryness of the skin, scale, turnover disorder, skin diseases (eg, dermatitis such as atopic dermatitis), hair loss, stains, wrinkles, freckles.
  • the composition of the present invention may further be a moisturizer, a skin-whitening agent, a hair restorer, or an anti-wrinkle agent (preferably a moisturizer, a hair-restorant, or an anti-wrinkle agent).
  • the composition of the present invention is at least two selected from the group consisting of a moisturizer, a skin lightening agent, a hair restorer, and an anti-wrinkle agent (preferably a moisturizer, a hair restorer and an anti-wrinkle agent) (eg, It may be an agent having two or three functions.
  • one or more water-soluble active ingredients are appropriately selected, and any method applicable to, for example, a desired site (eg, skin, hair, hair, scalp) according to a conventional method It can be carried out by preparing a formulation in the form of
  • the composition of the present invention may be a humectant.
  • the moisturizer of the present invention may preferably further contain a polyol as described above.
  • the humectant of the present invention may further contain, as a water-soluble active ingredient, other humectants as described above, in addition to the polyol.
  • the composition of the present invention can be used, for example, as a cosmetic for a site such as skin, hair or scalp.
  • the products for the skin include, for example, emulsions, lotions, creams, gels, essences and face masks.
  • Products for hair include, for example, hair emulsions, hair treatments, hair conditioners, shampoos, hair lotions.
  • the product for the scalp includes, for example, a hair restorer.
  • Preferred cosmetics include, for example, creams, gels, hair conditioners and hair treatments.
  • ⁇ Visual confirmation of gel-like composition The test sample prepared as described above is filled into a 50 ml glass vial and allowed to stand overnight. The next day, the glass vial was turned upside down, observed visually, and evaluated according to the following criteria. A: The gel does not fall. B: The gel maintains its shape slowly falling by gravity. C: The glass bottle drips as it is turned over. Do not maintain shape.
  • the test sample prepared as described above was subjected to strain dependence measurement of dynamic viscoelasticity using a rheometer (AR-G2, Tea Instrument) (measuring jig: aluminum cone plate diameter 40 mm) , Cone angle 2 °, measurement temperature: 35 ° C).
  • the thickness at the time of application was evaluated according to the following criteria by evaluating the vibrational stress at the intersection of the storage elastic modulus G ′ and the loss elastic modulus G ′ ′.
  • Vibrational stress at the intersection of storage elastic modulus G 'and loss elastic modulus G'' is 25 Pa or more
  • B Vibrational stress at the intersection of storage elastic modulus G' and loss elastic modulus G '' is 10 to 25 Pa
  • C Vibrational stress at the intersection of storage elastic modulus G ′ and loss elastic modulus G ′ ′ is less than 10 Pa
  • D Storage elastic modulus G ′ does not intersect loss elastic modulus G ′ ′
  • the storage modulus G ' is an indicator of the elastic properties of the material.
  • the loss modulus G ′ ′ is an indicator of the viscous nature of the material.
  • a viscous cosmetic preparation exhibits a relationship of storage elastic modulus G '> loss elastic modulus G' 'in a range where vibrational stress is very small, and when the preparation is stressed, loss elastic modulus G' '> Storage elastic modulus G'.
  • the thickness at the time of application increases as the intersection point of the storage elastic modulus G ′ and the loss elastic modulus G ′ ′ becomes higher stress side.
  • the thickness at the time of application is an objective index of the feeling of application (the comfort when the preparation is spread), and generally, when the thickness at application is increased, the improvement of the application feeling can be expected.
  • the composition (pH 4.0 to 7.0) containing guanosine phosphate (2.0% by weight or more) in the water-soluble medium was able to gel sufficiently and was excellent in the feeling of use (Tables 1 to 3).
  • composition pH 4.0 to 7.0
  • guanosine phosphoric acid (2.0% by weight or more) in a water-soluble medium

Abstract

The present invention provides a product using a thickener, which can be used instead of an anionic polymer and which has an excellent feeling of use. More specifically, the present invention provides a gel-type cosmetic composition comprising 2.0 wt% or more of a guanylic acid in a water-soluble medium and having a pH of 4.0-7.0.

Description

ゲル状化粧料組成物Gel-like cosmetic composition
 本発明は、ゲル状化粧料組成物に関する。 The present invention relates to a gel cosmetic composition.
 増粘剤は、多様な工業製品および食品等の広い分野の製品において使用されている。 Thickeners are used in a wide variety of products, such as various industrial products and food products.
 例えば、化粧料には、使用性や安定性等を高め、液だれを防ぐために増粘剤が使用される。例えば、カルボキシビニルポリマーなどのアニオン性水溶性ポリマーは、非常に安価で、増粘性が高く、少量でゲル化することに加え、刺激が少なく、透明性に優れ、べたつきの少ない良好な使用感であることから、スキンケアやヘアケアなど幅広い組成物の基剤増粘に汎用されている。しかしながら、アニオン性水溶性ポリマーの増粘機構は、カルボキシル基の中和によるものであるため、金属塩等の電解質が存在すると塩析効果により粘度が著しく低下し、所望の粘度を得ることが困難である(非特許文献1、特許文献1)。このような粘度低下を補うために、アニオン性水溶性ポリマーを多量に配合すると、塗布時にべたつきやヌルつきやべとつきを生じてしまい、使用感が損なわれるという本質的な欠点があった(特許文献2)。 For example, in cosmetics, thickeners are used to enhance usability and stability and to prevent dripping. For example, an anionic water-soluble polymer such as carboxyvinyl polymer is very inexpensive, highly thick, has a small amount of gelation in addition to gelation in a small amount, is excellent in transparency, has a good feeling of use with little stickiness Since it exists, it is widely used for base thickening of a wide range of compositions such as skin care and hair care. However, since the thickening mechanism of the anionic water-soluble polymer is due to neutralization of the carboxyl group, the presence of an electrolyte such as a metal salt significantly reduces the viscosity due to the salting-out effect, making it difficult to obtain the desired viscosity (Non-Patent Document 1, Patent Document 1). When an anionic water-soluble polymer is blended in a large amount to compensate for such a decrease in viscosity, stickiness, nulliness and stickiness occur during coating, resulting in an essential drawback that the feeling in use is impaired (Patent Document 1) 2).
 一方で、従来、スキンケアやヘアケアの化粧料には、さまざまな水溶性有効成分が提案されており、その多くが電解質から構成されている。例えば、天然保湿因子の構成成分であるアミノ酸、アミノ酸誘導体であるピロリドンカルボン酸ナトリウム、乳酸、ポリアミノ酸などの水溶性有効成分は、水分保持機能に優れ、肌に潤いを与えることができる。また、アスコルビン酸およびその誘導体、ならびにトラネキサム酸などの水溶性有効成分は、美白剤成分として、多くの化粧料に配合されている。 On the other hand, conventionally, various water-soluble active ingredients have been proposed for skin care and hair care cosmetics, and many of them are composed of electrolytes. For example, water-soluble active ingredients such as an amino acid which is a component of a natural moisturizing factor, sodium pyrrolidone carboxylate which is an amino acid derivative, lactic acid, a polyamino acid and the like have excellent water retention function and can moisturize the skin. In addition, ascorbic acid and its derivatives, and water-soluble active ingredients such as tranexamic acid are blended in many cosmetics as a skin-whitening ingredient.
 したがって、アニオン性高分子の代わりに使用することができ、かつ、電解質の存在にかかわらず、化粧料の使用感を向上できる増粘剤の開発が望まれている。 Therefore, it is desirable to develop a thickener which can be used in place of an anionic polymer and which can improve the feeling of use of a cosmetic regardless of the presence of an electrolyte.
 ところで、ヌクレオチドの一種であるアデノシン 5’-リン酸は、化粧料における有効成分(例、血行促進剤、育毛剤)として使用できることが報告されている(特許文献3、4)。また、グアニン類を含む美白強化剤が報告されている(特許文献5)。さらに、ヌクレオチドは、増粘剤として使用できることが報告されている(非特許文献2)。 By the way, it has been reported that adenosine 5'-phosphate, which is a kind of nucleotide, can be used as an active ingredient (for example, a blood circulation promoting agent, a hair restorer) in cosmetics (Patent Documents 3 and 4). In addition, a whitening agent containing guanine has been reported (Patent Document 5). Furthermore, it has been reported that nucleotides can be used as thickeners (Non-patent Document 2).
特開平8-99855号公報JP-A-8-99855 特開2005-120056号公報JP, 2005-120056, A 特許第3798927号公報Patent No. 3798927 gazette 特許第3957690号公報Patent No. 3957690 特許第5837497号公報Patent No. 583 7 497
 本発明の目的は、アニオン性高分子の代わりに使用することができ、かつ使用感に優れる増粘剤を利用して製品を開発することである。 An object of the present invention is to develop a product using a thickener which can be used instead of an anionic polymer and which is excellent in the feeling in use.
 本発明者らは、鋭意検討した結果、グアニル酸を高濃度で含む所定の組成物が所望の粘度特性を有し、しかも皮膚等の体表面に適用すると使用感に優れることを見出した。したがって、当該組成物は、多様な工業製品および食品等の広い分野における種々の用途のなかでも、日常的に高頻度で使用される嗜好品であり、使用感に対して高いニーズがある化粧料としての用途に特に適すると考えられる。 As a result of intensive investigations, the present inventors have found that a predetermined composition containing a high concentration of guanylate has desired viscosity characteristics, and moreover, when applied to a body surface such as skin, the feeling of use is excellent. Therefore, the composition is a favorite which is frequently used on a daily basis among various applications in a wide range of fields such as various industrial products and foods, and a cosmetic which has a high need for feeling in use Are considered particularly suitable for use as
 グアニル酸は、日常的に摂食されているうまみ成分であることから、ヒト等の被験体への安全性が高い成分と考えられる。したがって、安全性の観点でも、グアニル酸は、化粧料という用途に適している。 Guanylate is considered to be a highly safe component for subjects such as humans, because it is a umami component that is consumed on a daily basis. Therefore, also from the viewpoint of safety, guanylate is suitable for use as a cosmetic.
 本発明者らが把握する限り、化粧料の物性の調節または使用感の改善のためにグアニル酸を用いること、特に、電解質の存在にかかわらず、化粧料の使用感を向上できる増粘剤としてグアニル酸を用いることは知られていない。 As long as the present inventors understand, using guanilic acid for adjusting physical properties of cosmetics or improving the feeling of use, in particular, as a thickener capable of improving the feeling of using cosmetics regardless of the presence of an electrolyte It is not known to use guanylate.
 すなわち、本発明は、以下のとおりである。
〔1〕水溶性媒体中に2.0重量%以上のグアニル酸を含み、
 pH4.0~7.0である、ゲル状化粧料組成物。
〔2〕カチオン性物質をさらに含む、上記〔1〕のゲル状化粧料組成物。
〔3〕カチオン性物質が金属イオンである、上記〔1〕または〔2〕のゲル状化粧料組成物。
〔4〕グアニル酸の濃度が2.0~4.0重量%である、上記〔1〕~〔3〕のいずれかのゲル状化粧料組成物。
〔5〕pHが4.5~6.5である、上記〔1〕~〔4〕のいずれかのゲル状化粧料組成物。
〔6〕イノシン酸をさらに含む、上記〔1〕~〔5〕のいずれかのゲル状化粧料組成物。
〔7〕イノシン酸の濃度が0.1重量%以上である、上記〔6〕のゲル状化粧料組成物。
〔8〕水溶性有効成分をさらに含む、上記〔1〕~〔7〕のいずれかのゲル状化粧料組成物。
〔9〕ポリオールをさらに含む、上記〔1〕~〔8〕のいずれかのゲル状化粧料組成物。
〔10〕ゲル状化粧料組成物が、(i)RNA高分子、および/またはグアニル酸以外のRNA構成成分を完全に含まないものであるか、または(ii)グアニル酸以外のRNA構成成分をグアニル酸と同等の量において含まないものである、上記〔1〕~〔9〕のいずれかのゲル状化粧料組成物。
〔11〕ゲル状化粧料組成物が、定義された組成物である、上記〔1〕~〔10〕のいずれかのゲル状化粧料組成物。
〔12〕ゲル状化粧料組成物が保湿剤である、上記〔1〕~〔11〕のいずれかのゲル状化粧料組成物。
That is, the present invention is as follows.
[1] containing 2.0% by weight or more of guanylate in a water-soluble medium,
Gel cosmetic composition having a pH of 4.0 to 7.0.
[2] The gel cosmetic composition of the above-mentioned [1], which further comprises a cationic substance.
[3] The gel cosmetic composition according to the above [1] or [2], wherein the cationic substance is a metal ion.
[4] The gel cosmetic composition according to any one of the above [1] to [3], wherein the concentration of guanylate is 2.0 to 4.0% by weight.
[5] The gel cosmetic composition according to any one of the above [1] to [4], which has a pH of 4.5 to 6.5.
[6] The gel cosmetic composition according to any one of the above [1] to [5], which further contains inosinic acid.
[7] The gel cosmetic composition of the above-mentioned [6], wherein the concentration of inosinic acid is 0.1% by weight or more.
[8] The gel cosmetic composition according to any one of the above [1] to [7], which further comprises a water-soluble active ingredient.
[9] The gel cosmetic composition according to any one of the above [1] to [8], further comprising a polyol.
[10] The gel-like cosmetic composition is (i) completely free of RNA macromolecules and / or RNA constituents other than guanylate, or (ii) RNA constituents other than guanylate The gel cosmetic composition according to any one of the above [1] to [9], which is not contained in the same amount as guanyl acid.
[11] The gel cosmetic composition according to any one of the above [1] to [10], wherein the gel cosmetic composition is a defined composition.
[12] The gel cosmetic composition according to any one of the above [1] to [11], wherein the gel cosmetic composition is a moisturizing agent.
 グアニル酸を高濃度で含む本発明の化粧料組成物は、所望の粘度特性を有し、しかも使用感に優れるという効果を奏することができる。
 グアニル酸はヒト等の被験体への安全性が高い成分であると考えられることから、本発明の化粧料組成物は、安全性の観点でも優れているということができる。
The cosmetic composition of the present invention containing guanyl acid at a high concentration can exhibit the effects of having desired viscosity characteristics and being excellent in feeling in use.
Since guanylate is considered to be a highly safe component to subjects such as humans, it can be said that the cosmetic composition of the present invention is also excellent in terms of safety.
 本発明は、水溶性媒体中に2.0重量%以上のグアニル酸を含み。pH4.0~7.0である、ゲル状化粧料組成物(以下、単に「組成物」と呼称)を提供する。 The present invention comprises greater than 2.0% by weight of guanylate in an aqueous medium. A gel cosmetic composition (hereinafter simply referred to as “composition”) having a pH of 4.0 to 7.0 is provided.
 本発明の組成物は、本発明の組成物に含まれる他の成分(例、生理的に許容され得る塩、水溶性媒体、水溶性有効成分、ポリオール)の種類および濃度等の種々の条件によっても変動するが、水溶性媒体中に2.0重量%以上のグアニル酸を含み。pH4.0~7.0であることにより、水溶性媒体の十分なゲル化を達成することができる。本発明の組成物は、より高粘度のゲル化の達成、および/または使用感の向上等の観点から、より高い濃度(例、4.0重量%以上、5.0重量%以上、8.0重量%以上、10重量%以上)でグアニル酸を含むことができる。 The composition of the present invention depends on various conditions such as the type and concentration of other components (eg, physiologically acceptable salt, water-soluble medium, water-soluble active ingredient, polyol) contained in the composition of the present invention. It also varies, but contains more than 2.0% by weight of guanylate in a water-soluble medium. By having a pH of 4.0 to 7.0, sufficient gelling of the aqueous medium can be achieved. 8. The composition of the present invention has a higher concentration (e.g., 4.0% by weight or more, 5.0% by weight or more, and 8.) from the viewpoint of achieving higher viscosity gelation and / or improving the feeling in use, etc. Guanylic acid can be included at 0 wt% or more, 10 wt% or more).
 本発明の組成物はまた、使用量の低減によるコストの削減等の観点から、例えば50重量%以下、好ましくは30重量%以下、より好ましくは25重量%以下、さらにより好ましくは20重量%以下、特に好ましくは15重量%以下の濃度でグアニル酸を含んでいてもよい。 The composition of the present invention is also, for example, 50% by weight or less, preferably 30% by weight or less, more preferably 25% by weight or less, still more preferably 20% by weight or less, from the viewpoint of cost reduction due to reduction of use amount. It may contain guanylate, particularly preferably at a concentration of up to 15% by weight.
 あるいは、特定の使用感に着目して、グアニル酸の濃度が決定されてもよい。例えば、塗布時の厚みおよび/または塗布後のべたつきのなさに着目する場合、グアニル酸の濃度は、好ましくは2.0~4.0重量%であってもよい。 Alternatively, the concentration of guanylate may be determined focusing on a specific feeling of use. For example, when focusing on the thickness at the time of application and / or the non-stickiness after application, the concentration of guanylate may be preferably 2.0 to 4.0% by weight.
 ところで、グアニル酸(グアノシン 5’-モノリン酸)は、グアニン類(RNA構成成分)の一種であるため、従来の組成物(例、緩衝液)がRNA高分子(特に、抽出されたRNA高分子)を含む場合、RNA高分子の分解によりグアニル酸が生成する結果、従来の組成物中にグアニル酸が含まれる事態が想定される。しかし、本発明の組成物は、発明の技術的思想上、RNA高分子、ならびにグアニル酸以外のRNA構成成分〔例、グアニル酸以外のグアノシン 5’-リン酸(グアノシン 5’-ジリン酸およびグアノシン 5’-トリリン酸)、アデノシン 5’-リン酸、シチジン 5’-リン酸、ウリジン 5’-リン酸〕を実質的に含む必要がないことから、RNA高分子を含む従来の組成物と異なる。
 したがって、本発明の組成物は、(i)RNA高分子、および/またはグアニル酸以外のRNA構成成分を完全に含まないものであってもよい。
 本発明の組成物はまた、(ii)グアニル酸以外のRNA構成成分をグアニル酸と同等の量において含まないものであってもよい。RNA高分子を含む従来の組成物が、RNA高分子の分解により生成したグアニル酸を含む場合、同じくRNA高分子の分解により生成したグアニル酸以外のRNA構成成分の各々(例、グアニル酸以外のグアノシン 5’-リン酸、アデノシン 5’-リン酸、シチジン 5’-リン酸、ウリジン 5’-リン酸)もまた、グアニル酸と同等の量において含む事態が想定される。一方、本発明の組成物は、RNA高分子を実質的に含む必要がないため、グアニル酸以外の任意のRNA構成成分を、グアニル酸と同等の量において含むことを回避することができる。グアニル酸以外のRNA構成成分をグアニル酸と同等の量において含まないものとしては、グアニル酸以外の任意のRNA構成成分(例えば、グアニル酸以外のグアノシン 5’-リン酸、アデノシン 5’-リン酸、シチジン 5’-リン酸、ウリジン 5’-リン酸。好ましくは、これらの全体)がグアニル酸に対して、例えば1/2重量%以下、好ましくは1/5重量%以下、より好ましくは1/10重量%以下、さらにより好ましくは1/20重量%以下、特に好ましくは1/50重量%以下の量で含まれるものが挙げられる。本発明の組成物はまた、グアニル酸以外のRNA構成成分として、アデニン類(例、アデニン、アデノシン、アデノシン5’-モノリン酸、アデノシン5’-ジリン酸、アデノシン5’-トリリン酸、グルコシルアデノシン)を含まないものであってもよい。
By the way, since guanylate (guanosine 5'-monophosphate) is a kind of guanine (RNA component), RNA macromolecules (in particular, RNA macromolecules from which a conventional composition (eg, buffer solution) is extracted, in particular, In the case where the conventional composition contains guanylate, it is assumed that the conventional composition contains guanylate as a result of the formation of guanylate by the degradation of the RNA polymer. However, according to the technical idea of the present invention, the composition of the present invention is an RNA polymer and an RNA component other than guanylate [eg, guanosine 5'-phosphate other than guanylate (guanosine 5'-diphosphate and guanosine It differs from conventional compositions containing RNA macromolecules because it does not need to contain substantially 5'-triphosphate), adenosine 5'-phosphate, cytidine 5'-phosphate, uridine 5'-phosphate). .
Thus, the composition of the present invention may be completely free of (i) RNA macromolecules and / or RNA components other than guanylate.
The composition of the present invention may also contain (ii) no RNA component other than guanylate in an equivalent amount to guanylate. When the conventional composition containing RNA macromolecule contains guanylate produced by degradation of RNA macromolecule, each of the RNA components other than guanylate similarly produced by degradation of RNA macromolecule (eg, other than guanylate It is assumed that guanosine 5'-phosphate, adenosine 5'-phosphate, cytidine 5'-phosphate, uridine 5'-phosphate) is also included in the same amount as guanylate. On the other hand, since the composition of the present invention does not need to substantially contain RNA macromolecules, it can be avoided to contain any RNA component other than guanylate in an amount equivalent to guanylate. Examples of any RNA component other than guanylate (eg, guanosine 5'-phosphate, adenosine 5'-phosphate) other than guanylate that do not contain RNA components other than guanylate in equivalent amounts to guanylate (Cytidine 5'-phosphate, uridine 5'-phosphate, preferably all of them) is, for example, 1/2 wt.% Or less, preferably 1/5 wt. Those contained in an amount of at most 10% by weight, still more preferably at most 1/20% by weight, particularly preferably at most 1/50% by weight are mentioned. The composition of the present invention may also contain adenines (e.g., adenine, adenosine, adenosine 5'-monophosphate, adenosine 5'-diphosphate, adenosine 5'-triphosphate, glucosyl adenosine) as RNA components other than guanylate. May not be included.
 水溶性媒体としては、任意の水溶系溶媒を用いることができる。水溶性媒体としては、例えば、水溶液、および水溶液と有機溶媒との混合溶媒が挙げられる。水溶液は、緩衝能を有していてもいなくてもよい。水溶液としては、例えば、水(例、蒸留水、滅菌蒸留水、精製水、生理食塩水)、リン酸緩衝液、Tris-塩酸緩衝液、TE(Tris-EDTA)緩衝液、炭酸緩衝液、ホウ酸緩衝液、酒石酸緩衝液、グリシン緩衝液、クエン酸緩衝液、酢酸緩衝液が挙げられる。混合溶媒に含まれる有機溶媒としては、親水性有機溶媒(例、アルコール、アセトン)が好ましい。混合溶媒において、水溶液の容量は、特に限定されるものではないが、有機溶媒の容量よりも多いことが好ましい。混合溶媒における水溶液の容量は、有機溶媒の容量に比し、より好ましくは1.5倍以上であり、さらにより好ましくは2倍以上であり、特に好ましくは3倍以上、4倍以上または5倍以上であってもよい。水溶性媒体は、好ましくは水溶液であってもよく、より好ましくは水であってもよい。 Any water-soluble solvent can be used as the water-soluble medium. The water-soluble medium includes, for example, an aqueous solution, and a mixed solvent of an aqueous solution and an organic solvent. The aqueous solution may or may not have a buffering capacity. As the aqueous solution, for example, water (eg, distilled water, sterile distilled water, purified water, physiological saline), phosphate buffer, Tris-hydrochloric acid buffer, TE (Tris-EDTA) buffer, carbonate buffer, borax Acid buffer, tartaric acid buffer, glycine buffer, citrate buffer, acetate buffer may be mentioned. As the organic solvent contained in the mixed solvent, a hydrophilic organic solvent (eg, alcohol, acetone) is preferable. In the mixed solvent, the volume of the aqueous solution is not particularly limited, but is preferably larger than the volume of the organic solvent. The volume of the aqueous solution in the mixed solvent is more preferably 1.5 times or more, still more preferably 2 times or more, particularly preferably 3 times or more, 4 times or more or 5 times the volume of the organic solvent It may be more than. The aqueous medium may preferably be an aqueous solution, more preferably water.
 本発明の組成物はまた、水分含量の観点から規定することができる。例えば、本発明の組成物における水分含量は、本発明の組成物に含まれる他の成分の種類および濃度、ならびにpH等の種々の条件によっても変動するため特に限定されるものではないが、グアニル酸によるより高粘度のゲル化の達成、および/または使用感の向上等の観点から、例えば50重量%以上、好ましくは60重量%以上、より好ましくは70重量%以上であってもよい。水分含量はまた、例えば99.5重量%以下、好ましくは99重量%以下、より好ましくは98重量%以下であってもよい。より具体的には、水分含量は、例えば50~99.5重量%、好ましくは60~99重量%、より好ましくは70~98重量%であってもよい。 The compositions of the invention can also be defined in terms of water content. For example, the water content in the composition of the present invention is not particularly limited as it varies depending on the types and concentrations of other components contained in the composition of the present invention and various conditions such as pH, etc. From the viewpoint of achieving higher viscosity gelation with an acid and / or improving the feeling in use, it may be, for example, 50% by weight or more, preferably 60% by weight or more, and more preferably 70% by weight or more. The water content may also be, for example, 99.5 wt% or less, preferably 99 wt% or less, more preferably 98 wt% or less. More specifically, the water content may be, for example, 50 to 99.5% by weight, preferably 60 to 99% by weight, more preferably 70 to 98% by weight.
 本発明の組成物のpHは、4.0~7.0である。本発明の組成物は、pHが4.0~7.0の範囲内にあれば、グアニル酸によるゲル化の達成を十分に支援することができる。より高粘度のゲル化の達成、および/または使用感の向上等の観点から、pHは、4.5~6.5の範囲内にあることが好ましい。 The pH of the composition of the present invention is 4.0 to 7.0. The composition of the present invention can sufficiently support the achievement of gelation by guanylate when the pH is in the range of 4.0 to 7.0. The pH is preferably in the range of 4.5 to 6.5 from the viewpoint of achieving higher viscosity gelation and / or improving the feeling in use.
 本発明の組成物は、カチオン性物質をさらに含んでいてもよい。カチオン性物質としては、例えば、金属イオン、アルギニン、リジン、ヒスチジン、アンモニウムイオン、四級アミン(例、テトラアルキルアミン)が挙げられる。カチオン性物質は、グアニル酸によるゲルの形成を支援することができる。本発明の組成物は、1種または2種以上(例、2種、3種)のカチオン性物質を含むことができる。カチオン性物質としては、金属イオンが好ましい。金属イオンとしては、1価の金属イオン(例、ナトリウムイオン、カリウムイオン)、2価の金属イオン(例、カルシウムイオン、マグネシウムイオン、亜鉛イオン)、3価の金属イオン(例、アルミニウムイオン)が挙げられるが、溶解性等の観点から、1価の金属イオンが好ましい。カチオン性物質の濃度は、例えば0.01~5.0、好ましくは0.1~3.0、より好ましくは0.2~1.5であってもよい。 The composition of the present invention may further contain a cationic substance. Examples of cationic substances include metal ions, arginine, lysine, histidine, ammonium ions, and quaternary amines (eg, tetraalkylamines). Cationic substances can support the formation of gels by guanylate. The composition of the present invention can contain one or more (e.g., two or three) cationic substances. As the cationic substance, metal ions are preferred. As metal ions, monovalent metal ions (eg, sodium ion, potassium ion), divalent metal ions (eg, calcium ion, magnesium ion, zinc ion), trivalent metal ions (eg, aluminum ion) Although it may be mentioned, from the viewpoint of solubility etc., monovalent metal ions are preferred. The concentration of the cationic substance may be, for example, 0.01 to 5.0, preferably 0.1 to 3.0, and more preferably 0.2 to 1.5.
 本発明の組成物はまた、イノシン酸をさらに含んでいてもよい。イノシン酸は、グアニル酸との組合せにおいて、グアニル酸の作用を増強することができる。例えば、イノシン酸は、さっぱり感を増強することができる。イノシン酸は、日常的に摂食されているうまみ成分であることから、ヒト等の被験体への安全性が高い成分と考えられる。したがって、安全性の観点でも、イノシン酸は、化粧料という用途に適していると考えられる。 The compositions of the invention may also further comprise inosinic acid. Inosinic acid can enhance the action of guanylate in combination with guanylate. For example, inosinic acid can enhance refreshing feeling. Since inosinic acid is an umami component that is consumed on a daily basis, it is considered to be a component that is highly safe for subjects such as humans. Therefore, from the viewpoint of safety as well, inosinic acid is considered to be suitable for use as a cosmetic.
 本発明の組成物に含まれるイノシン酸の濃度は、本発明の組成物に含まれる他の成分の種類および濃度、ならびにpH等の種々の条件によっても変動するため特に限定されるものではないが、所望の作用の発揮の観点から、例えば0.05重量%以上、好ましくは0.1重量%以上、より好ましくは0.2重量%以上であってもよい。イノシン酸の濃度はまた、使用量の低減によるコストの削減等の観点から、例えば10重量%以下、好ましくは5重量%以下、より好ましくは2重量%以下、さらにより好ましくは1重量%以下、特に好ましくは0.5重量%以下の濃度であってもよい。 The concentration of inosinic acid contained in the composition of the present invention is not particularly limited because it also varies depending on the types and concentrations of other components contained in the composition of the present invention and various conditions such as pH. From the viewpoint of exerting the desired action, it may be, for example, 0.05% by weight or more, preferably 0.1% by weight or more, and more preferably 0.2% by weight or more. The concentration of inosinic acid is also, for example, 10% by weight or less, preferably 5% by weight or less, more preferably 2% by weight or less, and still more preferably 1% by weight or less, from the viewpoint of cost reduction due to reduction of use amount. Particularly preferably, the concentration may be 0.5% by weight or less.
 本発明の組成物はまた、所望の作用の発揮の観点から、グアニル酸に対するイノシン酸の相対量により特定することもできる。例えば、グアニル酸に対するイノシン酸の重量比(イノシン酸/グアニル酸)は、例えば1/100~1/1の範囲であってもよい。当該重量比は、好ましくは1/50~1/2、より好ましくは1/20~1/5の範囲であってもよい。 The composition of the present invention can also be specified by the relative amount of inosinic acid to guanylate in terms of exerting the desired action. For example, the weight ratio of inosine to guanylate (inosinic / guanylate) may be, for example, in the range of 1/100 to 1/1. The weight ratio may preferably be in the range of 1/50 to 1/2, more preferably 1/20 to 1/5.
 本発明の組成物はまた、ポリオールをさらに含んでいてもよい。ポリオールとしては、例えば、2価アルコール(例、エチレングリコール、プロピレングリコール、1,3-プロパンジオール、1,2-ブチレングリコール、1,3-ブチレングリコール、2,3-ブチレングリコール、1,4-ブタンジオール、2-ブテン-1,4-ジオール、1,5-ペンタンジオール、1,2-ペンタンジオール、イソプレングリコール、ヘキシレングリコール、ジエチレングリコール、ジプロピレングリコール)、3価アルコール(例、グリセリン、トリメチロールプロパン)、4価アルコール(例、ジグリセリン、ペンタエリスリトール、1,2,6-ヘキサントリオール)、より高い価数のアルコールが挙げられる。より高い価数のアルコールとしては、例えば、糖アルコール(例、ソルビトール、マンニトール等の単糖アルコール、トレハロース等の二糖アルコール、およびヒアルロン酸等の多糖アルコール)、ならびに上述したような2~4価アルコールの重合物(例、ポリグリコール、ポリグリセリン)が挙げられる。多価アルコールは、好ましくは、2~4価アルコールであり、より好ましくは、2価または3価アルコールである。1種または2種以上の多価アルコールを組み合わせて使用することができる。 The composition of the present invention may also further comprise a polyol. As the polyol, for example, a dihydric alcohol (eg, ethylene glycol, propylene glycol, 1,3-propanediol, 1,2-butylene glycol, 1,3-butylene glycol, 2,3-butylene glycol, 1,4-dioxane) Butanediol, 2-butene-1,4-diol, 1,5-pentanediol, 1,2-pentanediol, isoprene glycol, hexylene glycol, diethylene glycol, dipropylene glycol), trihydric alcohol (eg, glycerin, tri) Examples include methylolpropane), tetrahydric alcohols (eg, diglycerin, pentaerythritol, 1,2,6-hexanetriol), and higher value alcohols. Examples of higher valence alcohols include sugar alcohols (eg, monosaccharide alcohols such as sorbitol and mannitol, disaccharide alcohols such as trehalose, and polysaccharide alcohols such as hyaluronic acid), and di- to tetra-valent as described above. Polymers of alcohol (eg, polyglycol, polyglycerin) can be mentioned. The polyhydric alcohol is preferably a di- to tetra-hydric alcohol, more preferably a di- or tri-hydric alcohol. One or more types of polyhydric alcohols can be used in combination.
 本発明の組成物に含まれるポリオールの濃度は、本発明の組成物に含まれる他の成分の種類および濃度等の種々の条件によっても変動するため特に限定されるものではないが、例えば0.2重量%以上、好ましくは0.5重量%以上、より好ましくは1.0%重量%以上、さらにより好ましくは2.0重量%以上、特に好ましくは5.0重量%以上であってもよい。ポリオールの濃度はまた、使用量の低減によるコストの削減等の観点から、例えば30重量%以下、好ましくは25重量%以下、より好ましくは20重量%以下、さらにより好ましくは15重量%以下、特に好ましくは10重量%以下の濃度であってもよい。 The concentration of the polyol contained in the composition of the present invention is not particularly limited as it varies depending on various conditions such as the type and concentration of the other components contained in the composition of the present invention. It may be 2% by weight or more, preferably 0.5% by weight or more, more preferably 1.0% by weight or more, still more preferably 2.0% by weight or more, and particularly preferably 5.0% by weight or more . The concentration of the polyol is also, for example, 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, still more preferably 15% by weight or less, particularly from the viewpoint of cost reduction due to reduction of use amount. Preferably, the concentration may be 10% by weight or less.
 本発明の組成物はまた、1種または2種以上(例、2種、3種、4種)の水溶性有効成分をさらに含んでいてもよい。本発明で用いられる水溶性有効成分は、上述した成分以外の有効成分であって、化粧料として有用な任意の作用(例、生物学的作用、または化学的作用)を有するものである。 The composition of the present invention may further contain one or more (for example, two, three or four) water-soluble active ingredients. The water-soluble active ingredient used in the present invention is an active ingredient other than the above-mentioned ingredients and has any action (eg, biological action or chemical action) useful as a cosmetic.
 本発明で用いられる水溶性有効成分は、電解質であってもよい。したがって、本発明の組成物において、水溶性有効成分は、イオン性物質として存在していてもよい。イオン性物質としては、例えば、アニオン性部分を有するアニオン性物質、カチオン性部分を有するカチオン性物質、ならびにアニオン性部分およびカチオン性部分の双方を有する両イオン性物質が挙げられる。アニオン性部分としては、例えば、カルボキシレート基、ホスフェート基、スルホネート基、サルフェート基、二トレート基が挙げられる。カチオン性部分としては、アンモニウム基、ホスホニウム基、グアニジノ基、イミダゾイル基が挙げられる。アンモニウム基、およびホスホニウム基中の水素原子は、炭化水素基(例、アルキル)等の基で置換(例、モノ置換、ジ置換、トリ置換)されていてもよい。 The water-soluble active ingredient used in the present invention may be an electrolyte. Thus, in the compositions of the present invention, the water soluble active ingredient may be present as an ionic substance. The ionic substance includes, for example, an anionic substance having an anionic moiety, a cationic substance having a cationic moiety, and a zwitterionic substance having both an anionic moiety and a cationic moiety. The anionic moiety includes, for example, a carboxylate group, a phosphate group, a sulfonate group, a sulfate group and a ditorate group. The cationic moiety includes an ammonium group, a phosphonium group, a guanidino group and an imidazoyl group. The hydrogen atom in the ammonium group and the phosphonium group may be substituted (eg, mono-substituted, di-substituted, tri-substituted) with a group such as a hydrocarbon group (eg, alkyl).
 本発明で用いられる水溶性有効成分はまた、低分子化合物であってもよい。用語「低分子化合物」とは、分子量1500以下の化合物をいう。低分子化合物は、天然化合物または合成化合物である。低分子化合物の分子量は、1200以下、1000以下、900以下、800以下、700以下、600以下、500以下、400以下、または300以下であってもよい。低分子化合物の分子量はまた、30以上、40以上、または50以上であってもよい。低分子化合物としては、例えば、アミノ酸、オリゴペプチド、ビタミン、ヌクレオシド、ヌクレオチド、オリゴヌクレオチド、単糖、オリゴ糖、脂質、脂肪酸、およびそれらの代謝物が挙げられる。 The water-soluble active ingredient used in the present invention may also be a low molecular weight compound. The term "low molecular weight compound" refers to a compound having a molecular weight of 1,500 or less. Low molecular weight compounds are natural compounds or synthetic compounds. The molecular weight of the low molecular weight compound may be 1200 or less, 1000 or less, 900 or less, 800 or less, 700 or less, 600 or less, 500 or less, 400 or less, or 300 or less. The molecular weight of the low molecular weight compound may also be 30 or more, 40 or more, or 50 or more. The low molecular weight compounds include, for example, amino acids, oligopeptides, vitamins, nucleosides, nucleotides, oligonucleotides, monosaccharides, oligosaccharides, lipids, fatty acids, and metabolites thereof.
 本発明で用いられる水溶性有効成分はまた、保湿剤、美白剤、育毛剤、または抗シワ形成剤であってもよい。好ましくは、水溶性有効成分はまた、保湿剤、育毛剤、または抗シワ形成剤であってもよい。保湿剤、美白剤、育毛剤、および抗シワ形成剤(好ましくは、保湿剤、育毛剤、および抗シワ形成剤)からなる群より選ばれる2種以上(例、2種、3種)を組み合わせて使用することもできる。 The water soluble active ingredient used in the present invention may also be a moisturizer, a skin lightening agent, a hair restorer, or an anti-wrinkle agent. Preferably, the water soluble active ingredient may also be a moisturizer, a hair restorer, or an anti-wrinkle agent. A combination of two or more (for example, two or three) selected from the group consisting of a moisturizer, a whitening agent, a hair restorer, and an anti-wrinkle agent (preferably, a moisturizer, a hair restorer, and an anti-wrinkle agent) Can also be used.
 保湿剤としては、ピロリドンカルボン酸、アスコルビン酸 2-グルコシド、ポリアスパラギン酸、3-アセチル-2-エトキシカルボニル-2-メチル-1,3-チアゾリジン-4-カルボン酸、アミノ酸(例、グルタミン酸、アスパラギン酸、アルギニン、リジン、ヒスチジン、オルニチン、グリシン、アラニン、バリン、ロイシン、イソロイシン、セリン、スレオニン、アスパラギン、グルタミン、システイン、シスチン、メチオニン、フェニルアラニン、チロシン、トリプトファン、プロリン、ヒドロキシプロリン)およびそれらの混合物、グリシルグリシン、アラニルグルタミン、ジペプチド-2(バリルトリプトファン)、ジペプチド-4(システニルグリシン)、ジペプチド-8(アラニルヒドロキシプロリン)、ジペプチド-9(グルタミルリジン)、ジペプチド-11(システニルリジン)、ジペプチド-17(グリシルプロリン)、ジペプチド-19(ロイシルグルタミン酸)、ならびにそれらの塩が挙げられる。1種または2種以上の保湿剤を組み合わせて使用することができる。 Humectants include pyrrolidone carboxylic acid, ascorbic acid 2-glucoside, polyaspartic acid, 3-acetyl-2-ethoxycarbonyl-2-methyl-1,3-thiazolidine-4-carboxylic acid, amino acids (eg, glutamic acid, asparagine) Acid, arginine, lysine, histidine, ornithine, glycine, alanine, valine, leucine, isoleucine, serine, threonine, asparagine, glutamine, cysteine, cystine, methionine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline) and mixtures thereof Glycylglycine, alanyl glutamine, dipeptide-2 (valyl tryptophan), dipeptide-4 (cysteinylglycine), dipeptide-8 (alanyl hydroxyproline), dipepti -9 (Guru Tamil lysine), dipeptide 11 (system sulfonyl lysine), dipeptide -17 (glycyl proline), dipeptide -19 (isoleucyl glutamic acid), and salts thereof. One or more humectants can be used in combination.
 塩としては、例えば、無機塩および有機塩が挙げられる。無機塩としては、例えば、金属(例、ナトリウム、およびカリウム等の一価の金属、ならびにカルシウム、マグネシウム、および亜鉛等の二価の金属)の塩、無機酸(例、塩化水素、臭化水素、硫酸、およびリン酸)の塩、ならびに無機塩基(例、アンモニア)の塩が挙げられる。有機塩としては、例えば、有機酸(例、酢酸、乳酸、クエン酸、酒石酸、マレイン酸、フマル酸、モノメチル硫酸、アスパラギン酸、およびグルタミン酸)の塩、ならびに有機塩基(例、エチレンジアミン、プロピレンジアミン、エタノールアミン、モノアルキルエタノールアミン、ジアルキルエタノールアミン、ジエタノールアミン、トリエタノールアミン、リジン、アルギニン、ヒスチジン、オルニチン)の塩が挙げられる。 The salts include, for example, inorganic salts and organic salts. As the inorganic salt, for example, salts of metals (eg, monovalent metals such as sodium and potassium and divalent metals such as calcium, magnesium and zinc), inorganic acids (eg, hydrogen chloride, hydrogen bromide) And salts of sulfuric acid and phosphoric acid, and salts of inorganic bases (eg, ammonia). Examples of the organic salt include salts of organic acids (eg, acetic acid, lactic acid, citric acid, tartaric acid, maleic acid, fumaric acid, monomethyl sulfuric acid, aspartic acid, and glutamic acid), and organic bases (eg, ethylene diamine, propylene diamine, Salts of ethanolamine, monoalkylethanolamine, dialkylethanolamine, diethanolamine, triethanolamine, lysine, arginine, histidine, ornithine) can be mentioned.
 美白剤としては、例えば、ビタミンC、ビタミンC誘導体(例、L-アスコルビン酸 2-グリコシド等のビタミンC配糖体)、システイン、トラネキサム酸、ハイドロキノン、アルブチン、セラミド、コウジ酸、エラグ酸、植物抽出物、ならびにそれらの塩が挙げられる。1種または2種以上の美白剤を組み合わせて使用することができる。 Examples of skin lightening agents include vitamin C, vitamin C derivatives (eg, vitamin C glycosides such as L-ascorbic acid 2-glycoside), cysteine, tranexamic acid, hydroquinone, arbutin, ceramide, kojic acid, ellagic acid, plants Extracts as well as their salts are included. One or more kinds of skin lightening agents can be used in combination.
 育毛剤としては、例えば、パントテン酸およびその誘導体、アラントイン、ビオチン、モノニトログアヤコール、アデノシン、ペンタデカン酸グリセリド、ジアルキルモノアミン誘導体、コレウスエキス、クロロフィル、感光素、エストラジオール、エチニルエストラジオール、塩酸ピリドキシン、チオキソロン、ミノキシジル、硫黄、有機硫黄物質、ジペプチド-9(グルタミルリジン)、ならびにそれらの塩が挙げられる。1種または2種以上の育毛剤を組み合わせて使用することができる。 As a hair growth agent, for example, pantothenic acid and derivatives thereof, allantoin, biotin, mononitroguaiacol, adenosine, pentadecanoic acid glyceride, dialkyl monoamine derivative, choleus extract, chlorophyll, photosensitizer, estradiol, ethynyl estradiol, pyridoxine hydrochloride, thioxolone hydrochloride, minoxidil And sulfur, organic sulfur substances, dipeptide-9 (glutamyl lysine), and salts thereof. One or two or more hair growth agents can be used in combination.
 抗シワ形成剤としては、例えば、アルファヒドロキシ酸、パルミチン酸アスコルビルリン酸、テトラヘキシルデカン酸アスコルビル、アセチルヘキサペプチド-8、ならびにそれらの塩が挙げられる。1種または2種以上の抗シワ形成剤を組み合わせて使用することができる。 Anti-wrinkle agents include, for example, alpha hydroxy acids, ascorbyl palmitate, ascorbyl tetrahexyl decanoate, acetyl hexapeptide-8, and salts thereof. One or more anti-wrinkle agents can be used in combination.
 本発明の組成物は、定義された組成物であってもよい。本発明の組成物について用語「定義された」とは、本発明の組成物に含まれる成分および量が特定されていることを意味する。このような定義された組成物の調製は、既知成分を特定の量で用いることにより行うことができる。したがって、本発明の組成物は、成分またはその量が未知である材料、または成分またはその量が変動するおそれのある材料〔例、天然物(例、動物、植物、魚類、微生物等の生物、または鉱物等の非生物)〕から入手可能であるもの(例、抽出物、加工物)を含まないものであってもよい。 The composition of the present invention may be a defined composition. The term "defined" for the composition of the invention means that the ingredients and amounts contained in the composition of the invention are specified. The preparation of such defined compositions can be carried out by using known ingredients in specific amounts. Therefore, the composition of the present invention may be a material whose component or amount thereof is unknown, or a material whose component or amount may vary [eg, natural products (eg, animals such as animals, plants, fish, microorganisms, etc., Or non-living materials such as minerals) (eg, extracts, processed products) may not be included.
 本発明の組成物はまた、塗布時の厚み(塗布感)の観点から規定することができる。本発明の組成物は、貯蔵弾性率G’と損失弾性率G’’の交点の振動応力が10Pa以上であるという特性を備えることができる。貯蔵弾性率G’と損失弾性率G’’の交点の振動応力が10Pa以上であれば、塗布時の十分な厚み(塗布感)を期待することができる。このような交点の振動応力は、好ましくは15Pa以上であり、より好ましくは20Pa以上であり、さらにより好ましくは25Pa以上である。このような交点の振動応力の決定は、以下のとおり行うことができる。先ず、成分を混合し、pHを調整した組成物を、60℃の湯浴中で均一になるように撹拌し、室温まで徐冷して試験サンプルを得る。次に、試験サンプルをレオメーター(AR-G2、ティー・エイ・インスツルメント)を用いて、動的粘弾性のひずみ依存性測定を行えばよい(測定治具:アルミコーンプレート直径40mm、コーン角度2°、測定温度:35℃)。 The composition of the present invention can also be defined in terms of thickness (coating feeling) at the time of coating. The composition of the present invention can have the characteristic that the vibration stress at the intersection of the storage elastic modulus G 'and the loss elastic modulus G' 'is 10 Pa or more. If the vibration stress at the intersection of the storage elastic modulus G ′ and the loss elastic modulus G ′ ′ is 10 Pa or more, a sufficient thickness (application feeling) at the time of application can be expected. The vibration stress at such an intersection is preferably 15 Pa or more, more preferably 20 Pa or more, and still more preferably 25 Pa or more. Such determination of the vibrational stress at the point of intersection can be performed as follows. First, the components are mixed, and the pH-adjusted composition is uniformly stirred in a 60 ° C. water bath and gradually cooled to room temperature to obtain a test sample. Next, strain dependence measurement of dynamic viscoelasticity may be performed using a rheometer (AR-G2, TA Instruments) for a test sample (measuring jig: aluminum cone plate diameter 40 mm, cone Angle 2 °, measurement temperature: 35 ° C.).
 本発明の組成物はまた、上述した増粘性成分(例、グアニル酸)以外の増粘剤、安定化剤、pH調整剤、保存剤、紫外線防止剤、香料、色素等の他の成分を含んでいてもよい。これらの成分の具体的な種類および量は、適宜設定することができる。 The composition of the present invention also contains other components such as thickeners, stabilizers, pH adjusters, preservatives, UV inhibitors, perfumes, dyes, etc. other than the above-mentioned thickening components (eg, guanylate). It may be. The specific types and amounts of these components can be set as appropriate.
 上述した増粘性成分以外の増粘剤としては、例えば、カラギーナン、デキストリン、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ポリアクリル酸、ポリメタクリル酸、カルボキシビニルポリマー(カルボマー)、(アクリル酸/アクリル酸アルキル(C10-30))コポリマー、キサンタンガムが挙げられる。本発明の組成物が上述した増粘性成分に加えて、このような増粘剤を含む場合、上述した増粘性成分(例、グアニル酸)に対する増粘剤の重量比(増粘剤/増粘性成分)は、例えば1.0未満、好ましくは0.8未満、より好ましくは0.4未満、さらにより好ましくは0.2未満、特に好ましくは0.1未満であってもよい。 As thickeners other than the above-mentioned thickening component, for example, carrageenan, dextrin, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyacrylic acid, polymethacrylic acid, carboxyvinyl polymer (carbomer), ( And acrylic acid / alkyl acrylate (C10-30) copolymers, xanthan gum. When the composition of the present invention contains such a thickener in addition to the above-mentioned thickening component, the weight ratio of the thickening agent to the above-mentioned thickening component (eg, guanylate) (thickener / thickening property) The components) may for example be less than 1.0, preferably less than 0.8, more preferably less than 0.4, even more preferably less than 0.2, particularly preferably less than 0.1.
 安定化剤としては、例えば、アスコルビン酸、ピロ亜硫酸ナトリウム、EDTAが挙げられる。 Examples of the stabilizer include ascorbic acid, sodium metabisulfite and EDTA.
 pH調製剤としては、例えば、上述したような水溶液(緩衝液)、塩酸等の酸性物質、水酸化ナトリウム等の塩基性物質が挙げられる。 Examples of pH adjusting agents include aqueous solutions (buffer solutions) as described above, acidic substances such as hydrochloric acid, and basic substances such as sodium hydroxide.
 保存剤としては、例えば、パラオキシ安息香酸エチル、安息香酸ナトリウム、サリチル酸、ソルビン酸、パラベン(メチルパラベン、プロピルパラベン等)、亜硫酸水素ナトリウムが挙げられる。 Examples of preservatives include ethyl parahydroxybenzoate, sodium benzoate, salicylic acid, sorbic acid, parabens (such as methyl paraben and propyl paraben), and sodium bisulfite.
 紫外線防止剤としては、例えば、紫外線吸収剤(例、t-ブチルメトキシジベンゾイルメタン、メトキシケイヒ酸エチルヘキシル、オキシベンゾン-3)、および紫外線散乱剤(例、酸化チタン、酸化亜鉛)が挙げられる。 Examples of UV inhibitors include UV absorbers (eg, t-butyl methoxydibenzoylmethane, ethylhexyl methoxycinnamate, oxybenzone-3), and UV scattering agents (eg, titanium oxide, zinc oxide).
 香料としては、例えば、リモネン、シトラール、メントール、バラ油、ローズ油が挙げられる。 As the flavor, for example, limonene, citral, menthol, rose oil, rose oil can be mentioned.
 色素としては、例えば、有機顔料(例、赤色201号等の赤色顔料、青色404号等の青色顔料、橙色203号等の橙色顔料、黄色205号等の黄色顔料、緑色3号等の緑色顔料、ジルコニウムレーキ等の有機レーキ顔料、クロロフィル等の天然色素)、および無機顔料(例、酸化チタン等の白色顔料、酸化鉄等の有色顔料、タルク等の体質顔料、マイカ等のパール顔料)が挙げられる。 Examples of the pigment include organic pigments (eg, red pigment such as red No. 201, blue pigment such as blue No. 404, orange pigment such as orange No. 203, yellow pigment such as yellow No. 205, green pigment such as green No. 3) Organic lake pigments such as zirconium lake, natural pigments such as chlorophyll, and inorganic pigments (eg, white pigments such as titanium oxide, colored pigments such as iron oxide, extender pigments such as talc, pearl pigments such as mica) Be
 本発明の組成物は、被験体(例、ヒト等の哺乳動物、鳥類、爬虫類等の動物)の所望の部位(例、皮膚、毛髪、体毛、頭皮)に有効量(例、0.01mg~100g)を塗布することにより、用いることができる。被験体がヒトである場合、本発明の組成物の使用者でもあり適用者でもあり得るヒト(同一または異なるヒト)は、使用感の効果を享受することができる。被験体が動物である場合であっても、本発明の組成物はヒトにより通常使用されて動物に適用されるので、使用者であり得るヒトは、使用感の効果を享受することができる。好ましくは、被験体はヒトである。本発明の組成物が適用される被験体の状態は、上記部位が健常な状態を有するものであってもよく、または上記部位が異常な状態(例、疾患)を有するものであってもよい。このような異常な状態としては、例えば、肌荒れ、皮膚の乾燥、鱗屑、ターンオーバーの乱れ、皮膚疾患(例、アトピー性皮膚炎等の皮膚炎)、脱毛、しみ、しわ、そばかすが挙げられる。 The composition of the present invention is effective (e.g., 0.01 mg or more) at a desired site (e.g., skin, hair, body hair, scalp) of a subject (e.g., a mammal such as a human, animals such as birds, reptiles) It can be used by applying 100 g). When the subject is a human, a human (the same or different human) who can be a user or an applicator of the composition of the present invention can enjoy the effect of feeling of use. Even when the subject is an animal, since the composition of the present invention is usually used and applied to animals by humans, humans who can be users can enjoy the effect of feeling in use. Preferably, the subject is a human. The condition of the subject to which the composition of the present invention is applied may be that the above site has a healthy condition, or the above site may have an abnormal condition (eg, a disease) . Such abnormal conditions include, for example, rough skin, dryness of the skin, scale, turnover disorder, skin diseases (eg, dermatitis such as atopic dermatitis), hair loss, stains, wrinkles, freckles.
 本発明の組成物はさらに、保湿剤、美白剤、育毛剤、または抗シワ形成剤(好ましくは、保湿剤、育毛剤、または抗シワ形成剤)であってもよい。また、本発明の組成物は、保湿剤、美白剤、育毛剤、および抗シワ形成(好ましくは、保湿剤、育毛剤、および抗シワ形成剤)からなる群より選ばれる2種以上(例、2種、3種)の作用を併有する剤であってもよい。このような剤の調製は、1種または2種以上の水溶性有効成分を適宜選択して、常法にしたがって、例えば所望の部位(例、皮膚、毛髪、体毛、頭皮)に適用可能な任意の形態の製剤とすることにより行うことができる。 The composition of the present invention may further be a moisturizer, a skin-whitening agent, a hair restorer, or an anti-wrinkle agent (preferably a moisturizer, a hair-restorant, or an anti-wrinkle agent). In addition, the composition of the present invention is at least two selected from the group consisting of a moisturizer, a skin lightening agent, a hair restorer, and an anti-wrinkle agent (preferably a moisturizer, a hair restorer and an anti-wrinkle agent) (eg, It may be an agent having two or three functions. For preparation of such an agent, one or more water-soluble active ingredients are appropriately selected, and any method applicable to, for example, a desired site (eg, skin, hair, hair, scalp) according to a conventional method It can be carried out by preparing a formulation in the form of
 好ましくは、本発明の組成物は、保湿剤であってもよい。この場合、本発明の保湿剤は、好ましくは、上述したようなポリオールをさらに含んでいてもよい。本発明の保湿剤はまた、ポリオールに加えて、上述したような他の保湿剤を水溶性有効成分としてさらに含んでいてもよい。 Preferably, the composition of the present invention may be a humectant. In this case, the moisturizer of the present invention may preferably further contain a polyol as described above. The humectant of the present invention may further contain, as a water-soluble active ingredient, other humectants as described above, in addition to the polyol.
 本発明の組成物は、例えば、皮膚、毛髪、または頭皮等の部位に対する化粧料として用いることができる。皮膚に対する製品としては、例えば、乳液、化粧水、クリーム、ジェル、美容液、フェイスマスクが挙げられる。毛髪に対する製品としては、例えば、毛髪用乳液、ヘアトリートメント、ヘアコンディショナー、シャンプー、ヘアローションが挙げられる。頭皮に対する製品としては、例えば、育毛剤が挙げられる。好ましい化粧料としては、例えば、クリーム、ジェル、ヘアコンディショナー、ヘアトリートメントが挙げられる。 The composition of the present invention can be used, for example, as a cosmetic for a site such as skin, hair or scalp. The products for the skin include, for example, emulsions, lotions, creams, gels, essences and face masks. Products for hair include, for example, hair emulsions, hair treatments, hair conditioners, shampoos, hair lotions. The product for the scalp includes, for example, a hair restorer. Preferred cosmetics include, for example, creams, gels, hair conditioners and hair treatments.
 次に実施例を示して本発明をさらに詳細に説明するが、本発明は以下の実施例に限定されるものではない。 EXAMPLES The present invention will next be described in more detail by way of examples, which should not be construed as limiting the invention thereto.
<実施例1~6、比較例1~7の組成物の調製>
 あらかじめ水に撹拌して分散させた成分(A)または高分子に対して、ポリオールを加えた。成分(A)としては、グアニル酸(グアノシン 5’-モノリン酸)、および/またはイノシン酸(イノシン 5’-モノリン酸)(いずれも塩ではない)を用いた。次いで、水溶性有効成分を加え、室温にてよく撹拌し、得られた組成物のpHを、pH調整剤を用いて、表に記載のとおり調整した。その後、60℃の湯浴中で均一になるように撹拌し、室温まで徐冷することで試験サンプルを得た。
Preparation of Compositions of Examples 1 to 6 and Comparative Examples 1 to 7
The polyol was added to the component (A) or polymer which was previously stirred and dispersed in water. As the component (A), guanylate (guanosine 5'-monophosphate) and / or inosinic acid (inosine 5'-monophosphate) (both not salts) were used. Subsequently, the water-soluble active ingredient was added, well stirred at room temperature, and the pH of the obtained composition was adjusted as described in the table using a pH adjuster. Thereafter, the mixture was uniformly stirred in a 60 ° C. water bath and gradually cooled to room temperature to obtain a test sample.
<ゲル状組成物の目視確認>
 前記のように調製した試験サンプルを50mlのガラスバイアル瓶に充填し、一晩静置する。翌日、ガラスバイアル瓶を逆さにして、目視にて観察し、下記の基準にて評価した。
 A:ゲルが落ちてこない。
 B:ゲルが重力により、ゆっくりと落ちてくるものの形状は維持している。
 C:ガラス瓶をひっくり返すと同時に垂れる。形状を維持しない。
<Visual confirmation of gel-like composition>
The test sample prepared as described above is filled into a 50 ml glass vial and allowed to stand overnight. The next day, the glass vial was turned upside down, observed visually, and evaluated according to the following criteria.
A: The gel does not fall.
B: The gel maintains its shape slowly falling by gravity.
C: The glass bottle drips as it is turned over. Do not maintain shape.
<ゲル状組成物の破断応力>
 前記のように調製した試験サンプルを50mlのガラスバイアル瓶に充填し、FUDOHレオメーターRTC-3010D-CW(株式会社レオテック製)を用いて、破断応力を25℃で測定した。得られた測定値を下記の基準にて評価した。
 A:5g以上である場合
 B:0.5g~4.9gである場合
 C:0.49g以下の場合
<Breaking stress of gel-like composition>
The test sample prepared as described above was filled in a 50 ml glass vial, and the breaking stress was measured at 25 ° C. using a FUDOH rheometer RTC-3010D-CW (manufactured by Leotec Co., Ltd.). The obtained measured values were evaluated according to the following criteria.
A: 5 g or more B: 0.5 g to 4.9 g C: 0.49 g or less
<塗布時の厚みの評価>
 前記のように調製した試験サンプルをレオメーター(AR-G2、ティー・エイ・インスツルメント)を用いて、動的粘弾性のひずみ依存性測定を行った(測定治具:アルミコーンプレート直径40mm、コーン角度2°、測定温度:35℃)。貯蔵弾性率G’と損失弾性率G’’の交点の振動応力を評価することにより、塗布時の厚みを下記の基準に従い、評価した。
 A:貯蔵弾性率G’と損失弾性率G’’の交点の振動応力が25Pa以上
 B:貯蔵弾性率G’と損失弾性率G’’の交点の振動応力が10~25Pa
 C:貯蔵弾性率G’と損失弾性率G’’の交点の振動応力が10Pa未満
 D:貯蔵弾性率G’と損失弾性率G’’が交わらない
<Evaluation of thickness at the time of application>
The test sample prepared as described above was subjected to strain dependence measurement of dynamic viscoelasticity using a rheometer (AR-G2, Tea Instrument) (measuring jig: aluminum cone plate diameter 40 mm) , Cone angle 2 °, measurement temperature: 35 ° C). The thickness at the time of application was evaluated according to the following criteria by evaluating the vibrational stress at the intersection of the storage elastic modulus G ′ and the loss elastic modulus G ′ ′.
A: Vibrational stress at the intersection of storage elastic modulus G 'and loss elastic modulus G''is 25 Pa or more B: Vibrational stress at the intersection of storage elastic modulus G' and loss elastic modulus G '' is 10 to 25 Pa
C: Vibrational stress at the intersection of storage elastic modulus G ′ and loss elastic modulus G ′ ′ is less than 10 Pa D: Storage elastic modulus G ′ does not intersect loss elastic modulus G ′ ′
 貯蔵弾性率G’は、物質の弾性的性質の指標である。損失弾性率G’’は、物質の粘性的性質の指標である。一般的に、粘性を持った化粧品製剤は、振動応力が微小の範囲で、貯蔵弾性率G’>損失弾性率G’’の関係を示し、製剤に応力を加えていくと損失弾性率G’’>貯蔵弾性率G’となる。貯蔵弾性率G’と損失弾性率G’’の交点が高応力側になるにつれて、内部構造を破壊するのに大きな力が必要であることを意味する。したがって、貯蔵弾性率G’と損失弾性率G’’の交点が高応力側になるにつれて、塗布時の厚みが増加していくことを示す。塗布時の厚みは、塗布感(製剤を塗り広げた際の心地よさ)の客観的な一指標となるものであり、一般的に、塗布時の厚みが増すと塗布感の向上が期待できる。 The storage modulus G 'is an indicator of the elastic properties of the material. The loss modulus G ′ ′ is an indicator of the viscous nature of the material. In general, a viscous cosmetic preparation exhibits a relationship of storage elastic modulus G '> loss elastic modulus G' 'in a range where vibrational stress is very small, and when the preparation is stressed, loss elastic modulus G' '> Storage elastic modulus G'. As the intersection point of the storage elastic modulus G 'and the loss elastic modulus G' 'is on the high stress side, it means that a large force is required to break the internal structure. Therefore, it indicates that the thickness at the time of application increases as the intersection point of the storage elastic modulus G ′ and the loss elastic modulus G ′ ′ becomes higher stress side. The thickness at the time of application is an objective index of the feeling of application (the comfort when the preparation is spread), and generally, when the thickness at application is increased, the improvement of the application feeling can be expected.
<官能評価試験>
[評価方法]
 専門評価パネル10名による使用テストを行い、塗布感、さっぱり感、及びさらさら感、べたつきのなさについて下記評価基準により5段階評価し、さらにその平均点を算出した後、下記判定基準により判定した。
<Sensory evaluation test>
[Evaluation method]
The use test was conducted by 10 professional evaluation panels, and the application feeling, the refreshing feeling, the dry feeling, and the non-stickiness were evaluated in 5 steps according to the following evaluation criteria, and their average points were calculated.
[評価基準]
5点:非常に良好
4点:良好
3点:ふつう
2点:やや不良
1点:不良
[Evaluation criteria]
5 points: very good 4 points: good 3 points: normal 2 points: somewhat bad 1 point: bad
[判定基準]
A:平均点4点以上
B:平均点3点以上~4点未満
C:平均点2点以上~3点未満
D:平均点2点未満
Judgment criteria
A: Average point of 4 points or more B: Average point of 3 points or more to less than 4 points C: Average point of 2 points or more to less than 3 points D: Average point of less than 2 points
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
 その結果、水溶性媒体中にグアノシンリン酸(2.0重量%以上)を含む組成物(pH4.0~7.0)は、十分にゲル化することでき、しかも使用感に優れていた(表1~3)。 As a result, the composition (pH 4.0 to 7.0) containing guanosine phosphate (2.0% by weight or more) in the water-soluble medium was able to gel sufficiently and was excellent in the feeling of use ( Tables 1 to 3).
 したがって、水溶性媒体中にグアノシンリン酸(2.0重量%以上)を含む組成物(pH4.0~7.0)は、化粧料としての用途に適していることが確認された。 Therefore, it was confirmed that a composition (pH 4.0 to 7.0) containing guanosine phosphoric acid (2.0% by weight or more) in a water-soluble medium is suitable for use as a cosmetic.

Claims (12)

  1.  水溶性媒体中に2.0重量%以上のグアニル酸を含み、
     pH4.0~7.0である、ゲル状化粧料組成物。
    Containing at least 2.0% by weight of guanylate in an aqueous medium,
    Gel cosmetic composition having a pH of 4.0 to 7.0.
  2.  カチオン性物質をさらに含む、請求項1記載のゲル状化粧料組成物。 The gel cosmetic composition according to claim 1, further comprising a cationic substance.
  3.  カチオン性物質が金属イオンである、請求項1または2記載のゲル状化粧料組成物。 The gel-like cosmetic composition according to claim 1 or 2, wherein the cationic substance is a metal ion.
  4.  グアニル酸の濃度が2.0~4.0重量%である、請求項1~3のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any one of claims 1 to 3, wherein the concentration of guanylate is 2.0 to 4.0% by weight.
  5.  pHが4.5~6.5である、請求項1~4のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any one of claims 1 to 4, which has a pH of 4.5 to 6.5.
  6.  イノシン酸をさらに含む、請求項1~5のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any one of claims 1 to 5, further comprising inosinic acid.
  7.  イノシン酸の濃度が0.1重量%以上である、請求項6記載のゲル状化粧料組成物。 The gel cosmetic composition according to claim 6, wherein the concentration of inosinic acid is 0.1% by weight or more.
  8.  水溶性有効成分をさらに含む、請求項1~7のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any one of claims 1 to 7, further comprising a water-soluble active ingredient.
  9.  ポリオールをさらに含む、請求項1~8のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any one of claims 1 to 8, further comprising a polyol.
  10.  ゲル状化粧料組成物が、(i)RNA高分子、および/またはグアニル酸以外のRNA構成成分を完全に含まないものであるか、または(ii)グアニル酸以外のRNA構成成分をグアニル酸と同等の量において含まないものである、請求項1~9のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition is (i) completely free of RNA macromolecules and / or RNA constituents other than guanylate, or (ii) RNA constituents other than guanylate with guanylate The gel cosmetic composition according to any one of claims 1 to 9, which is not contained in the same amount.
  11.  ゲル状化粧料組成物が、定義された組成物である、請求項1~10のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any of the preceding claims, wherein the gel cosmetic composition is a defined composition.
  12.  ゲル状化粧料組成物が保湿剤である、請求項1~11のいずれか一項記載のゲル状化粧料組成物。 The gel cosmetic composition according to any one of claims 1 to 11, wherein the gel cosmetic composition is a moisturizing agent.
PCT/JP2018/006791 2017-08-17 2018-02-23 Gel-type cosmetic composition WO2019035227A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-157366 2017-08-17
JP2017157366 2017-08-17

Publications (1)

Publication Number Publication Date
WO2019035227A1 true WO2019035227A1 (en) 2019-02-21

Family

ID=65362806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/006791 WO2019035227A1 (en) 2017-08-17 2018-02-23 Gel-type cosmetic composition

Country Status (1)

Country Link
WO (1) WO2019035227A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021200855A1 (en) * 2020-03-31 2021-10-07 ユニテックフーズ株式会社 Protein gel

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001019610A (en) * 1999-07-08 2001-01-23 Noevir Co Ltd Skin preparation for external use
JP2003095912A (en) * 2001-09-20 2003-04-03 Noevir Co Ltd Skin care preparation
US20030133961A1 (en) * 2000-07-13 2003-07-17 Kazuo Nakamura Cosmetic compositions for reducing and method of using the same
JP2007308431A (en) * 2006-05-19 2007-11-29 Kamioka Seimitsu Kagaku Kk Bath medicine
WO2012017911A1 (en) * 2010-08-03 2012-02-09 株式会社林原生物化学研究所 Agent for enhancing whitening effect and use of same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001019610A (en) * 1999-07-08 2001-01-23 Noevir Co Ltd Skin preparation for external use
US20030133961A1 (en) * 2000-07-13 2003-07-17 Kazuo Nakamura Cosmetic compositions for reducing and method of using the same
JP2003095912A (en) * 2001-09-20 2003-04-03 Noevir Co Ltd Skin care preparation
JP2007308431A (en) * 2006-05-19 2007-11-29 Kamioka Seimitsu Kagaku Kk Bath medicine
WO2012017911A1 (en) * 2010-08-03 2012-02-09 株式会社林原生物化学研究所 Agent for enhancing whitening effect and use of same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021200855A1 (en) * 2020-03-31 2021-10-07 ユニテックフーズ株式会社 Protein gel

Similar Documents

Publication Publication Date Title
JP4322124B2 (en) Method for stabilizing bubbles in foam-containing cosmetics
EP3185850B1 (en) Skin color-improving agent and composition for improving skin color
KR102091794B1 (en) Dispersion liquid and hydrogel formation method
JP6275296B2 (en) Mitochondrial function improving agent and production method
WO2016076310A1 (en) Moisturizing agent
ES2726452T3 (en) Cosmetic for skin in oil-in-water emulsion
KR20160100931A (en) Stick-shaped base material containing lipid-peptide compound
EP3808329A1 (en) Coating film-forming composition
JP2008285421A (en) Hair modification penetrant and cosmetic for hair using the same
JP5546253B2 (en) Composition for external use
WO2022170114A1 (en) Skincare compositions and methods of use thereof
WO2019035227A1 (en) Gel-type cosmetic composition
KR102294367B1 (en) A method for adjusting the hardness of a stick-like substrate containing a lipopeptide compound
JP6757130B2 (en) A composition having an azulene compound, and a discoloration inhibitor and a discoloration prevention method for the azulene compound.
KR20180019599A (en) A stick-shaped substrate comprising a lipid peptide-type compound
JP2006225271A (en) Agent for preventing or ameliorating wrinkle
JP2019137695A (en) Method for permeation of skin active ingredient
JP2010189368A (en) Liquid external preparation for skin
JP7340796B2 (en) cosmetics
JP2008247754A (en) Composition for external application
JP2007077101A (en) External preparation for skin
JP2018118957A (en) Gelatinous composition
JP2018043974A (en) Cosmetic
JPH10194964A (en) Emulsion composition
JP7377526B2 (en) Skin cosmetic composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18845854

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18845854

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP